Search results
Results from the WOW.Com Content Network
BARDA provided initial funding of $20 million but could provide up to $100 million over a period of 4–5 years. [ 40 ] In 2017, BARDA signed a three-year $8.1 million contract with InBios International, Inc. of Seattle, Washington to develop a “ point-of-care diagnostic test that may be able to determine within 15 minutes whether a patient ...
The funding from the award will be disbursed in two installments, with an initial sum of about $65.7 million accessible immediately to facilitate ongoing study start-up endeavors.
Brings total awards from BARDA to $110 million for development of broad SARS-CoV-2 and Influenza multispecifics, with potential funding of up to $205 million if all options are executed; Development work is based on ModeX proprietary MSTAR technology that incorporates multiple antibody binding sites into a single molecule
The new award follows a $483 million grant provided by BARDA in April, which means Moderna has now received a total of $955 million in funding from the U.S. government.The award coincides with the ...
Spoof of National Review. [21] NBC.com.co NBC.com.co Imitates NBC. [23] [21] NBCNews.com.co NBCNews.com.co Defunct Mimics the URL, design and logo of NBC News. [24] News Examiner newsexaminer.net Started in 2015 by Paul Horner, the lead writer of the National Report. This website has been known to mix real news along with its fake news. [25]
By David Bautz, PhD NASDAQ:CFRX READ THE FULL CFRX RESEARCH REPORT Business Update BARDA Contract to Support Development of Exebacase On March 11, 2021, ContraFect Corp. (NASDAQ:CFRX) announced an ...
The scheme ran from May 2007 but started to run out of funds by October as investors asked for their money back. Safevest LLC returned $18 million to investors, the rest having been split among five main expenditures, including the two business partners' families, the purchase of a $1 million golf course, and $950,000 for GTS Research Inc.
The funding is part of a partnership with the Biomedical Advanced Research and Development Authority (BARDA). Under the multi-year contract CSL will deliver its MF59 adjuvant, an ingredient that ...